Skip to main content
. Author manuscript; available in PMC: 2016 Oct 4.
Published in final edited form as: Nat Rev Nephrol. 2011 Apr 19;7(6):348–355. doi: 10.1038/nrneph.2011.50

Table 1.

Spectrum of ADEs in patients with kidney dysfunction

Study ADE category Example
Miller et al. (2009)46
Zand et al. (2010)47
Inappropriate medication dosing
for level of kidney function
Gabapentin 300 mg three times daily in a patient with an eGFR of
20 ml/min/1.73 m2, leading to central nervous system depression
Williams et al. (2004)48
Sica et al. (2004)49
Drug–drug interactions in
patients with advanced CKD
Increased risk of bradycardia with atenolol and diltiazem (drugs
cleared via the kidney) in a patient with end-stage renal disease
Chen (2009)50 Inappropriate prescribing Use of morphine in a patient with stage 5 CKD, leading to
accumulation of active metabolites
Bernstein et al. (1990)51 Inadequate monitoring High levels of aminoglycoside in a patient receiving antibiotics for
a prolonged period of time
Connolly et al. (2009)52 Failure to identify CKD Reliance on serum creatinine concentration alone to assess renal
function in an elderly patient
Perazella et al. (2009)53 Inappropriate diagnostic test Use of gadolinium for MRI contrast in a patient with stage 5 CKD

Abbreviations: ADE, adverse drug event; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.